224 related articles for article (PubMed ID: 23109704)
41. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
[TBL] [Abstract][Full Text] [Related]
42. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of familial breast cancer.
Lee H; Geng C; Cheng M; Lee Z; Guo Z
Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Sep; 27(5):3082-5. PubMed ID: 27158866
[TBL] [Abstract][Full Text] [Related]
43. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
Wendt C; Margolin S
Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
[TBL] [Abstract][Full Text] [Related]
44. A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data.
Melloni GEM; Mazzarella L; Bernard L; Bodini M; Russo A; Luzi L; Pelicci PG; Riva L
Breast Cancer Res; 2017 May; 19(1):63. PubMed ID: 28569218
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide association studies and the clinic: a focus on breast cancer.
Véron A; Blein S; Cox DG
Biomark Med; 2014; 8(2):287-96. PubMed ID: 24521025
[TBL] [Abstract][Full Text] [Related]
46. Genetic risk transmission in a family affected by familial breast cancer.
Pilato B; De Summa S; Danza K; Lacalamita R; Lambo R; Sambiasi D; Paradiso A; Tommasi S
J Hum Genet; 2014 Jan; 59(1):51-3. PubMed ID: 24152768
[TBL] [Abstract][Full Text] [Related]
47. Uptake of polygenic risk information among women at increased risk of breast cancer.
Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
[TBL] [Abstract][Full Text] [Related]
48. Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population.
Näslund-Koch C; Nordestgaard BG; Bojesen SE
Ann Oncol; 2017 Jan; 28(1):175-181. PubMed ID: 28177461
[TBL] [Abstract][Full Text] [Related]
49. A genetic variant at 12p11 significantly modifies breast cancer risk in a genetically homogenous island population.
McVeigh TP; McVeigh UM; Sweeney KJ; Kerin MJ; Miller N
Breast Cancer Res Treat; 2015 Jan; 149(1):41-7. PubMed ID: 25476496
[TBL] [Abstract][Full Text] [Related]
50. Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.
Lilyquist J; Ruddy KJ; Vachon CM; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):380-394. PubMed ID: 29382703
[TBL] [Abstract][Full Text] [Related]
51. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Yanes T; Young MA; Meiser B; James PA
Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
[TBL] [Abstract][Full Text] [Related]
52. A polygenic risk score for breast cancer risk in a Taiwanese population.
Hsieh YC; Tu SH; Su CT; Cho EC; Wu CH; Hsieh MC; Lin SY; Liu YR; Hung CS; Chiou HY
Breast Cancer Res Treat; 2017 May; 163(1):131-138. PubMed ID: 28205043
[TBL] [Abstract][Full Text] [Related]
53. Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Young MA; Forrest LE; Rasmussen VM; James P; Mitchell G; Sawyer SD; Reeve K; Hallowell N
J Genet Couns; 2018 Jun; 27(3):702-708. PubMed ID: 29168041
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
55. Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer.
Wirtenberger M; Tchatchou S; Hemminki K; Klaes R; Schmutzler RK; Bermejo JL; Chen B; Wappenschmidt B; Meindl A; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Mar; 27(3):593-8. PubMed ID: 16234258
[TBL] [Abstract][Full Text] [Related]
56. Women's responses and understanding of polygenic breast cancer risk information.
Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA
Fam Cancer; 2020 Oct; 19(4):297-306. PubMed ID: 32430685
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Li H; Feng B; Miron A; Chen X; Beesley J; Bimeh E; Barrowdale D; John EM; Daly MB; Andrulis IL; Buys SS; Kraft P; ; Thorne H; Chenevix-Trench G; Southey MC; Antoniou AC; James PA; Terry MB; Phillips KA; Hopper JL; Mitchell G; Goldgar DE
Genet Med; 2017 Jan; 19(1):30-35. PubMed ID: 27171545
[TBL] [Abstract][Full Text] [Related]
58. The role of polygenic risk and susceptibility genes in breast cancer over the course of life.
Mars N; Widén E; Kerminen S; Meretoja T; Pirinen M; Della Briotta Parolo P; Palta P; ; Palotie A; Kaprio J; Joensuu H; Daly M; Ripatti S
Nat Commun; 2020 Dec; 11(1):6383. PubMed ID: 33318493
[TBL] [Abstract][Full Text] [Related]
59. Variation in predictive ability of common genetic variants by established strata: the example of breast cancer and age.
Aschard H; Zaitlen N; Lindström S; Kraft P
Epidemiology; 2015 Jan; 26(1):51-8. PubMed ID: 25380502
[TBL] [Abstract][Full Text] [Related]
60. Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'.
Willis AM; Smith SK; Meiser B; James PA; Ballinger ML; Thomas DM; Yanes T; Young MA
J Genet Couns; 2021 Jun; 30(3):849-860. PubMed ID: 33470033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
